526445 — Indrayani Biotech Income Statement
0.000.00%
Last trade - 00:00- IN₹708.09m
- IN₹2.09bn
- IN₹1.30bn
Annual income statement for Indrayani Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 211 | 616 | 1,629 | 1,662 | 1,302 |
| Cost of Revenue | |||||
| Gross Profit | 49.8 | 202 | 607 | 624 | 475 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 265 | 555 | 1,496 | 1,464 | 1,273 |
| Operating Profit | -54 | 61.2 | 134 | 199 | 28.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -112 | 44.6 | 123 | 110 | -57.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -112 | 44.6 | 119 | 104 | -61.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -112 | 44.6 | 119 | 104 | -61.1 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -112 | 44.4 | 119 | 104 | -61.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.28 | 1.3 | 2.86 | 2.68 | -1.35 |
| Dividends per Share |